Clinical Significance:1. Screening of Herceptin, Tykerb, T-DM1 and other targeted drugs, breast cancer HER-2 overexpression, advanced gastric cancer, patients with gastro-esophageal junction adenocarcinoma may choose targeted drugs therapy
2. Evaluate the prognosis of breast cancer, the prognosis of patients with HER-2 gene amplification is poor, the disease-free survival period and the total survival period are significantly shortened
3. Guidance for breast cancer endocrine therapy, HER-2 gene amplification in patients under endocrine therapy is not sensitive
4. Guide breast cancer adjuvant chemotherapy drug selection, HER-2 gene amplification in patients with high degree of malignancy, decreased responsiveness to CMF chemotherapy regimen, paclitaxel and anthracycline-based high-intensity chemotherapy drugs should be recommended.
Storage and Stability:Store powder at 4°C liquid at -20°C. Store other components at 4°C. Stable for 6 months For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
